Skip to content
Lower risk Drug recall · FDA · Published March 4, 2025

Major Pharmaceuticals Tolterodine Capsules Recall: Failed Dissolution Testing

Major Pharmaceuticals recalls 2mg Tolterodine Extended-Release Capsules due to failed dissolution testing in stability checks. This may affect medication effectiveness. Check your NDC 0904-6592-04 lot numbers.

🇺🇸 FDA recall #D-0304-2025DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling 2mg Tolterodine Tartrate Extended-Release Capsules because stability testing showed they didn't dissolve properly. This could mean the medication isn't working as intended, so affected users should stop using the product. Read more at govinfonow.com/recall/32252-major-pharmaceuticals-tolterodine-capsules-recall-failed-dissolution-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/32252-major-pharmaceuticals-tolterodine-capsules-recall-failed-dissolution-testing · Updated August 17, 2026 · FDA enforcement record: FDA #D-0304-2025

Cite this page

“Major Pharmaceuticals Tolterodine Capsules Recall: Failed Dissolution Testing.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32252-major-pharmaceuticals-tolterodine-capsules-recall-failed-dissolution-testing. Based on FDA recall #D-0304-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0304-2025%22&limit=1).

The FDA announced on March 4, 2025, that Major Pharmaceuticals is recalling Tolterodine Tartrate Extended-Release Capsules due to failed dissolution specifications. The recall affects 224 cartons distributed nationwide.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton
  • NDC: 0904-6592-04
  • Lot#: T05393
  • Exp. Date: 09/30/2025

The hazard

The recall is due to out-of-specification results obtained during routine stability testing for dissolution, according to the FDA.

Context

GovInfoNow's records show The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories has had 14 other recalls since May 31, 2023. Recent brand recalls include a September 12, 2025 recall for N-Nitroso Desmethyl Chlorpromazine Risk and a September 2, 2025 recall for Foreign Substance Hazard. Other recent recalls of similar products include Sun Pharmaceutical Lisdexamfetamine Capsules Recall (October 28, 2025) and Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall (August 31, 2026).

How to tell if you have this one

Check for the NDC code 0904-6592-04 on the carton. The lot number T05393 and expiration date 09/30/2025 are specific to this recall.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 0904-6592-04 and lot number T05393 on the carton.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Mar 4, 202512. FDA classified it Class III: Mar 28, 202523. Published in FDA’s Enforcement Report: Apr 9, 202534. FDA terminated the recall: Feb 23, 2026420252026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0304-2025 (March 4, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0304-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA